Skip to content Skip to footer
Close

Dr. Patrik Säterö

M.D.

Patrik Säterö lives and work in Gothenburg, Sweden as a PMNR, and is also a qualified physical therapist. Botulinum toxin has been the main tool for Patrik since 2005 in treating spasticity, chronic migraine and hyperhidrosis. He has his own private clinic since 2014, Rehdo.

Prof. Monica Verduzco-Gutierrez

M.D.

Dr. Monica Verduzco-Gutierrez is an accomplished academic Physiatrist and Professor and Chair of the Department of Rehabilitation Medicine at the Long School of Medicine at UT Health San Antonio. She previously was the Medical Director of the Brain Injury and Stroke Program at TIRR Memorial Hermann Hospital, a top four US News and World Report Best Hospital for Rehabilitation.

Dr. Franco Molteni

M.D.

Dr. Luis Jorge Jacinto

M.D.

© 2025 ToxNet. All Rights Reserved.

Supported by Merz Therapeutics GmbH

Liability for links
Our site contains links to external websites, over which we have no control. Therefore we cannot accept any responsibility for this external content. The respective provider or operator is always responsible for the contents of any linked site. At the time of linking the linked sites where checked for possible legal violations. At the time of linking illegal contents were not indicated. A permanent control of the linked pages is unreasonable without concrete evidence of violation. Upon notification of violations, we will remove such links immediately.

Award scoring criteria

The following criteria will be judged out of a score of 5; (1 is suboptimal; 2 is adequate; 3 is good; 4 is very good; 5 is excellent)

GENERAL

  • Days per week working in spasticity management
  • Average number of spasticity patients managed per month
  • Environment and clinical team (type of institution, location, size/structure of clinical team, particular patient needs)
  • Role of responsibility in managing patients with spasticity
  • Scientific appointments in spasticity
  • Honours for work undertaken in spasticity

SCHOLARLY

  • Number of research projects investigating relevant aspects of spasticity management
  • Impact of research projects investigating relevant aspects of spasticity management
  • Number of peer-reviewed publications on topic
    Number of presentations of research at international meetings
  • Number of presentations at national conferences
  • Teaching/mentorship of younger injectors
  • h-index

CLINICAL

  • Evidence of development or growth of a spasticity program at the applicant’s practice or institution
  • Breadth of services provided, including medications, toxins, physical interventions, and Intrathecal Baclofen Therapy (ITB)
  • Role of responsibility in managing patients with spasticity

ENDORSEMENT

  • Endorsed by senior peer

In the event of a tie, based on the above scoring criteria, the Toxnet Co-Chairs will make the final decision.